A Review on Cerebrotendinous Xanthomatosis (CTX): A Rare Autosomal Recessive Inherited Disease

Authors

  • Ritik Kashyap Department of Pharmacy Practice, Aditya College of Pharmacy, Surampalem, Andhra Pradesh, India
  • Kumar Akash Saha Department of Pharmacy Practice, Aditya College of Pharmacy, Surampalem, Andhra Pradesh, India
  • Devakar L Department of Pharmacy Practice, Aditya College of Pharmacy, Surampalem, Andhra Pradesh, India
  • Amit Kumar Department of Pharmacy Practice, Aditya College of Pharmacy, Surampalem, Andhra Pradesh, India

DOI:

https://doi.org/10.61427/jcpr.v.i..70

Keywords:

Cerebrotendinous Xanthomatosis, Bile Acid, Cholesterol

Abstract

Cerebrotendinous Xanthomatosis (CTX) is a rare autosomal recessive disease which is caused due to the mutation of CYP27A1 gene that encodes sterol 27-hydroxylase enzyme. Due to the pathogenic variation in this enzyme the bile acid synthesis pathway gets disturbed which results in the production of bile acid intermediates especially cholesterol & bile alcohols and these gets accumulated in various parts of the body resulting in formation of xanthomas. There is no permanent cure for CTX but the early detection and treatment with cholic and chenodexycholic acids have proven to reduce the severity of the condition. CTX is a genetic disease which generally prevails from the early childhood and lasts throughout the life. Thus, proper genetic counseling is recommended to help families understand the genetics and natural history of CTX, and also to provide the psychosocial support.

Downloads

Download data is not yet available.

References

Andrea E DeBarber, P Barton Duell. Update on cerebrotendinous xanthomatosis. Curr Opin Lipidol, 2021; 32(2): 123-31.

Satyadev Vadapalli. Cerebrotendinous Xanthomatosis. Indian J Orthop, 2013; 47(2):200-3.

Shingo Koyama, Takeo Kato. Pathophysiology of cerebrotendinous xanthomatosis. Rinsho Shinkeigaku, 2016; 56(12): 821-6.

Shingo Koyama, Yoshiki Sekijima et al. Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis and Disease-Modifying Treatments. J Atheroscler Thromb.2021; 28(9): 905-25.

Shuke Nie, Guiqin Chen et al. Cerebrotendinous xanthomatosis: A comprehensive review of pathogenesis, clinical manifestations, diagnosis and management. Orphaned J Rare Dis. 2014; 9:179.

Published

2022-10-25
Statistics
248 Views | 273 Downloads
Citatons

How to Cite

Kashyap, R. ., K. A. . Saha, D. L, and A. . Kumar. “A Review on Cerebrotendinous Xanthomatosis (CTX): A Rare Autosomal Recessive Inherited Disease”. Journal of Clinical and Pharmaceutical Research, Oct. 2022, pp. 55-57, doi:10.61427/jcpr.v.i. 70.

Issue

Section

Review Articles

Most read articles by the same author(s)